Ingredient

Empagliflozin Amorphous

Empagliflozin is a glucose control ingredient used in the treatment of type 2 diabetes.

See medicines used for Chronic Conditions
All medicines
26
Single ingredient
4
Combination
22
Prescription medication
26

MFDS ingredient code M280507

What does it do?

Empagliflozin is a component of the SGLT2 inhibitor class of diabetes medications. This ingredient is used for the purpose of lowering blood glucose by blocking the reabsorption of glucose in the kidneys.

Empagliflozin inhibits the sodium-glucose co-transporter 2 (SGLT2) in the kidneys, allowing glucose to be excreted in the urine. This helps reduce excessive glucose levels in the blood, aiding in blood glucose control.

Commonly used for

Approved uses differ by product. Check each product's information for its actual use.

Good to know

Empagliflozin is characterized by its proven cardiovascular protective effects compared to other SGLT2 inhibitors. It is also often formulated in an amorphous form, which can improve absorption and contribute to effective blood glucose control.

Medicines containing this ingredient

Even with the same ingredient, strength, dosage form and how it is taken can differ.

Category
Dosage form
Strength
Category

26 total

View more

Even with the same ingredient, dosage and approved uses can differ by strength, dosage form and combined ingredients. Check each product's information before taking it.

Combined ingredients

Ingredients used together with this ingredient in combination products.

Questions about this ingredient

No questions yet.

For anything that needs medical judgment, consult a doctor or pharmacist.

SourceKorea Ministry of Food and Drug Safety (Drug Safety Korea)

This drug information is based on data provided by the Korea Ministry of Food and Drug Safety.
Consult a doctor or pharmacist for accurate dosage, administration, and usage instructions.